Cargando…
Use of Autoantigen-Loaded Phosphatidylserine-Liposomes to Arrest Autoimmunity in Type 1 Diabetes
INTRODUCTION: The development of new therapies to induce self-tolerance has been an important medical health challenge in type 1 diabetes. An ideal immunotherapy should inhibit the autoimmune attack, avoid systemic side effects and allow β-cell regeneration. Based on the immunomodulatory effects of...
Autores principales: | Pujol-Autonell, Irma, Serracant-Prat, Arnau, Cano-Sarabia, Mary, Ampudia, Rosa M., Rodriguez-Fernandez, Silvia, Sanchez, Alex, Izquierdo, Cristina, Stratmann, Thomas, Puig-Domingo, Manuel, Maspoch, Daniel, Verdaguer, Joan, Vives-Pi, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454589/ https://www.ncbi.nlm.nih.gov/pubmed/26039878 http://dx.doi.org/10.1371/journal.pone.0127057 |
Ejemplares similares
-
Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry
por: Rodriguez-Fernandez, Silvia, et al.
Publicado: (2018) -
Efferocytosis Promotes Suppressive Effects on Dendritic Cells through Prostaglandin E2 Production in the Context of Autoimmunity
por: Pujol-Autonell, Irma, et al.
Publicado: (2013) -
Immunotherapy with Tolerogenic Dendritic Cells Alone or in Combination with Rapamycin Does Not Reverse Diabetes in NOD Mice
por: Pujol-Autonell, Irma, et al.
Publicado: (2013) -
Antigen-specific immunotherapy combined with a regenerative drug in the treatment of experimental type 1 diabetes
por: Villalba, Adrian, et al.
Publicado: (2020) -
Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming
por: Villalba, Adrian, et al.
Publicado: (2020)